Zcash’s Dramatic Surge Over the Past 90 Days Underscores Rising Demand for Privacy-Enabled, Institution-Ready Digital Assets; Supports Reliance’s Focused Digital Asset Treasury StrategyLAKEWOOD, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has completed a strategic realignment of its Digital Asset Treasury (“DAT”), by consolidating its digital asset position into Zcash (ZEC). The Company has fully exited its prio ...

Accessibility StatementSkip Navigation HONG KONG, Nov. 25, 2025 /PRNewswire/ -- mF International Limited (Nasdaq: MFI) ("mF" or the "Company") announced today that Mr. Haoyu Wang has resigned from his position of CEO, director, and chief compliance officer ("CCO") of the Company effective November 24, 2025. Mr. Dawei Yuan, an entrepreneur with extensive experience in blockchain infrastructure development and security, has been appointed by the board of directors (the "Board") to succeed Mr. Wang as CEO of ...

Accessibility StatementSkip Navigation Company Holds 382.9384 Bitcoin and $37.25 Million of Cash Allocated for Future Purchases of Bitcoin LAS VEGAS, Nov. 25, 2025 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced that its Bitcoin treasury, including current holdings and cash allocated to committed purchases of Bitcoin, totaled approximately $70.5 million, based on the p ...

Core Insights - Enlivex Therapeutics has entered into a private investment in public equity (PIPE) agreement to sell 212 million ordinary shares at $1.00 per share, raising approximately $212 million, which will be used to implement a RAIN prediction markets token treasury strategy [3][8][9] - The company will be the first publicly-listed entity to adopt a treasury strategy centered on the RAIN token, aiming to provide investors with exposure to the rapidly growing prediction markets sector [5][9] - Enlivex continues its focus on the clinical development of Allocetra™, a novel therapy for knee osteoarthritis, a condition affecting over 32.5 million Americans [10] Company Developments - The PIPE transaction represents a premium of 11.5% from the stock's closing price on November 21, 2025 [3][8] - Matteo Renzi, former Prime Minister of Italy, will join the Enlivex Board of Directors following the closing of the private placement [2] - The closing of the transaction is expected on or before November 25, 2025, pending customary closing conditions [5] Industry Context - The prediction markets industry is experiencing significant institutional interest, highlighted by a $2 billion investment by NYSE's parent company in Polymarket and a $300 million financing round for Kalshi led by prominent venture capital firms [5] - RAIN is a decentralized predictions and options protocol built on the Arbitrum network, allowing users to create and trade custom options on various markets [4] - The protocol features a deflationary Buyback & Burn mechanism and aims to be a leading platform in the prediction markets space, similar to Uniswap in decentralized finance [4]

Core Insights - Enlivex Therapeutics is set to implement a unique treasury strategy centered around the RAIN prediction markets token, marking it as the first publicly-listed company to do so in the U.S. [1][8] - The company is continuing the clinical development of Allocetra™, a therapy aimed at treating knee osteoarthritis, addressing a significant unmet medical need in a growing market [2][9] - The private placement transaction involves the sale of 212 million ordinary shares at $1.00 per share, yielding approximately $212 million in gross proceeds [3] Company Developments - Enlivex will appoint former Italian Prime Minister Matteo Renzi to its Board of Directors following the private placement [2] - The company plans to utilize the net proceeds from the PIPE transaction to implement the RAIN treasury strategy while maintaining focus on its core business operations [3][5] - The price per share for the private placement represents an 11.5% premium over the previous closing price [2] Industry Context - The prediction markets sector is experiencing significant institutional interest, highlighted by a $2 billion investment in Polymarket and a $300 million financing round for Kalshi [5] - RAIN is described as a fully decentralized predictions and options protocol, allowing users to create and trade custom options on various markets [4] - The market for osteoarthritis treatments is substantial, with over 32.5 million Americans affected and projections indicating that 78 million Americans may have osteoarthritis by 2040 [9]

Accessibility StatementSkip Navigation HONG KONG, Nov. 21, 2025 /PRNewswire/ -- mF International Limited (Nasdaq: MFI) ("mF" or the "Company"), today announced a $500.0 million private placement, or PIPE, with accredited institutional investors in connection with its plans to initiate a digital asset treasury strategy. The PIPE is expected to involve the sale of 50 million of the Company's class A ordinary shares and pre-funded warrants at a purchase price of $10.00 per class A ordinary share. mF expects to ...

Solana Company (NasdaqCM:HSDT) Q3 2025 Earnings Call November 18, 2025 04:30 PM ET Company ParticipantsDane Andreeff - CEOSerena Jassy - Head of Investor RelationsCosmo Jiang - DirectorJoseph Chee - Executive ChairmanJeff S. Mathiesen - CFOOperatorHello, and thank you for standing by. Welcome to Solana Company's Third Quarter Operating Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a Question-and-Answer session. To ask a que ...

Financial Data and Key Metrics Changes - The third quarter revenue was $697,000, which included first-time staking rewards income of $342,000, marking a significant increase from the prior year period [25] - Cost of revenue decreased to $103,000 from $187,000 in the prior year, primarily due to reduced inventory reserve and production scrap expenses [25] - Total operating expenses for Q3 2025 were $36 million, compared to $3.9 million in Q3 2024, resulting in a loss from operations of $35.4 million, up from a loss of $4.1 million in the prior year [26] - The net loss for Q3 2025 was $352.8 million, or a loss of $32.89 per share, compared to a net loss of $3.7 million in the prior year [27][28] Business Line Data and Key Metrics Changes - The company has increased its holdings of SOL by approximately 100,000 tokens in the first month of operation, totaling over 2.3 million tokens [15] - The average gross staking yield for October was 7.03% APY, outperforming the stake-weighted average of the top 10 largest validators [16] Market Data and Key Metrics Changes - Trading volume in HSDC has significantly outperformed the average of peer DATs, indicating growing awareness of Solana's fundamentals [10] - The company has been actively engaging with institutional investors and has appeared in major media outlets, enhancing its visibility in the market [8] Company Strategy and Development Direction - The company aims to build the "Berkshire Hathaway of the Solana ecosystem," focusing on maximizing shareholder value through disciplined execution of its digital asset treasury strategy [11] - The strategic focus includes advocacy for Solana, capital markets management, and treasury management, with an emphasis on operational excellence and capital discipline [14][15] Management's Comments on Operating Environment and Future Outlook - Management acknowledged a cooling digital asset treasury market but expressed confidence in the company's ability to navigate the execution and consolidation phase [12][14] - The company believes it has the necessary ingredients for long-term success, including balance sheet strength and institutional sponsorship [15] Other Important Information - The company successfully raised over $500 million to fund its digital asset treasury strategy in September 2025 [4] - The PONS device has shown positive clinical outcomes, supporting its submission for FDA 510(k) designation [22] Q&A Session Summary - No questions were raised during the Q&A session, indicating a lack of immediate inquiries from investors [30]

In October announced a $25 million share repurchase program, advancing LITS from the initial phase of Litecoin accumulation to active capital market operations and allowing LITS to leverage our nearly 1 million LTC treasury - a key differential from passive investment structures like exchange-traded funds.Rebranded from MEI Pharma to Lite Strategy, including changing the Company’s corporate name and NASDAQ Stock Market ticker from MEIP to LITS, and unveiling a new corporate logo and website. The rebranding ...

Financial Data and Key Metrics Changes - The company concluded Q3 2025 with $182,000 in cash and cash equivalents, down from $612,000 as of December 31, 2024 [13] - The net loss for Q3 2025 was $77.7 million, compared to a loss of $3.1 million in Q3 2024, primarily due to a $74.4 million loss on remeasurement of a derivative liability [13] - Revenue for Q3 2025 was $3.6 million, largely unchanged from $3.9 million in the same period in 2024 [14] - General and administrative expenses increased to $2.6 million in Q3 2025 from $1.5 million in Q3 2024 [15] Business Line Data and Key Metrics Changes - The company launched a digital asset treasury strategy focused on Aethir's ATH token, representing a new business line aimed at generating revenue through AI infrastructure [3][4] - The investment in ATH tokens is expected to create a new revenue stream by converting tokens into GPU compute capacity [6][7] Market Data and Key Metrics Changes - AI infrastructure spending is projected to reach $2.8 trillion globally by 2029, indicating a significant growth opportunity for the company [7][26] - The demand for AI compute power is outpacing supply by more than 10 times, highlighting a critical market need [26][27] Company Strategy and Development Direction - The company aims to leverage its strategic compute reserve to democratize access to AI infrastructure while generating revenue [7][39] - The digital asset strategy includes passive staking, active staking, GPU leasing, and token rotation to diversify revenue sources [18][20] - The company plans to utilize ATH tokens to rent GPUs and provide AI infrastructure to enterprises, creating a virtuous cycle of revenue generation [30][39] Management's Comments on Operating Environment and Future Outlook - Management emphasized the importance of building a strategic compute reserve to address the growing demand for AI infrastructure [27][39] - The company is optimistic about its partnership with Aethir and the potential for significant revenue growth in the AI infrastructure market [40] Other Important Information - The company holds approximately 5.7 billion ATH tokens with a market value of approximately $145.9 million as of November 10, 2025 [17] - The strategic compute reserve is expected to allow the company to onboard NVIDIA's latest GPUs to meet enterprise demand [39] Q&A Session Summary Question: What is the company's strategy regarding the ATH tokens? - The company plans to actively manage ATH tokens through staking, leasing, and token rotation to maximize returns and generate cash flow [18][20] Question: How does the company plan to address the supply-demand imbalance in AI infrastructure? - The company aims to stimulate supply by monetizing ATH holdings and providing GPU access to enterprises, addressing the critical shortage in AI infrastructure [27][30]